`To:
`Cc:
`
`Subject:
`Date:
`Attachments:
`
`Stephen Underwood
`Director_PTABDecision_Review
`josephpalys@paulhastings.com; naveenmodi@paulhastings.com; chetanbansal@paulhastings.com; Lawrence
`Hadley
`Request for Director Rehearing in IPR2016-00908
`Thursday, September 2, 2021 1:34:01 PM
`image002.png
`2021-09-02 IPR2016-00908 Request for Director Rehearing.pdf
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Dear Sir or Madam:
`
`Hello; I represent Patent Owner UUSI, LLC d/b/a Nartron (“Nartron”) in pending IPR2016-00908. This
`case is currently on appeal at the Federal Circuit in CAFC Case No. 21-1060. However, on August 3,
`2021, the Federal Circuit remanded the case “for the limited purpose of allowing appellant [Nartron]
`the opportunity to request Director rehearing of the final written decision,” in view of the Arthrex
`decision. CAFC Case No. 21-1060, Paper 36. The Federal Circuit directed Nartron to file any Request
`for Director Rehearing “within 30 days from the date of this order.” Id.
`
`Today, Nartron filed a Request for Director Rehearing of the Final Written Decision (Paper 53) on
`PTAB E2E. A copy of the Request for Director Rehearing is also attached to this email. The Request is
`timely because it was filed within the 30-day period set by the Federal Circuit. Nartron respectfully
`requests consideration of its Request for Director Rehearing, and asks that—for the reasons stated
`in the Request—the Final Written Decision be reheard by the Director.
`
`Respectfully submitted,
`
`Stephen Underwood
`Reg. No. 77,977
`
`Stephen Underwood| Associate
`10250 Constellation Blvd., 19th Floor, Los Angeles, CA 90067
`Main: 310.553.3000 | Direct: 310.282.6223| Fax: 310.785-3523
`E-Mail: sunderwood@glaserweil.com | www.glaserweil.com
`
`This message and any attached documents may contain information from the law firm of Glaser Weil Fink Howard Avchen & Shapiro LLP
`that is confidential and/or privileged. If you are not the intended recipient, you may not read, copy, distribute or use this information. If
`you have received this transmission in error, please notify the sender immediately by reply e-mail and then delete this message
`
`Although some Glaser Weil attorneys and staff still are working remotely in order to reduce
`the risks associated with COVID-19, we all will continue doing our utmost to provide prompt,
`IPR2016-00908
`Ex. 3100
`
`
`
`professional service to and on behalf of our clients.
`
`This email has been scanned for viruses and malware, and may have been automatically archived by
`Mimecast, a leader in email security and cyber resilience. Mimecast integrates email defenses with brand
`protection, security awareness training, web security, compliance and other essential capabilities. Mimecast
`helps protect large and small organizations from malicious activity, human error and technology failure; and
`to lead the movement toward building a more resilient world. To find out more, visit our website.
`
`